verified that USP35 could maintain the stability of its protein by deubiquitinating FPN1, and reduce the iron disorder triggered by erastin/RSL3, thereby promoting lung cancer cell growth and tumor progression. The gene discussed is USP35; the disease is lung carcinoma.